Before reading this article, please click "Follow", which is not only convenient for you to discuss and share, but also can bring you a different sense of participation, thank you for your support!
Body:
Recently, in the well-known NBA league, Shake Milton, the second-in-command player of the Philadelphia 76ers, showed an excellent performance against the Los Angeles Clippers - shooting 15 of 29 and scoring 37 points.
Such a bombardment and scoring not only aroused heated discussions among fans, but also aroused people's attention to the internal decision-making of the 76ers. Needless to say, the reason for Nas's outstanding performance is not just his individual level, the second leader of the 76ers really needs to make a substitution.
According to the latest media reports, the performance of the 76ers' second-in-command Al Horford has been quite sluggish recently. Although Obaud joined the 76ers in 2019 with a high salary of $30 million, his on-court performance fell far short of the expectations of the team and fans. Meanwhile, Nurse Simus' accurate shooting on the court and his all-around performance on both ends of the floor have led to the idea that it's time to tweak the starting lineup and give Nas more playing time.
On the one hand, Nass's outstanding performance is not only a reflection of his individual strength, but also the role he plays within the team.
In the past games, Nas has not only scored calmly and comfortably in key moments, but has also shown excellent playmaking and defensive awareness. In contrast, Obaud's performance on the field has been frequently wrong and unable to recover. When the team needs consistent scoring points and a calm playmaker, Nas's ability is even better.
On the other hand, the overall interests of the team also require more play with Nas as a starter. Recently, the Philadelphia 76ers have faced some difficulties in terms of record and standings, which need to seek changes and breakthroughs. As a young and promising player, Nurse can not only provide consistent scoring points for the team on the offensive end, but also play an active role on the defensive end.
Therefore, giving Nas more minutes and higher expectations will help the team achieve a better record in the playoff race.
In alternating between plays, Nas also proved his sense of responsibility and adaptability to the team. He always puts the interests of the team first and actively integrates into the team's tactical system. His outstanding performance has also been recognized and supported by head coach Brett Brown, who said that Nas's decision was the right one and that his performance had a positive impact on the team.
Of course, when changing the starting line-up, Aubid's value in the team and his ability to come in handy also need to be fully considered.
Whether it's adjusting the starting lineup or increasing Nurse's playing time, the 76ers should focus on the overall strategy and the stability of the team. When Nurse becomes a starter, he will have more opportunities to show his individual abilities and build a better chemistry with other core players. Obade, on the other hand, has the opportunity to take on more important tasks as a substitute, providing tactical and experienced support to the team.
Overall, Nurse Simus' stellar 37-point run against the Los Angeles Clippers raised questions about the Philadelphia 76ers' lineup and decision-making.
His all-round ability and consistent performance undoubtedly bring greater competitiveness to the team. Changing the starting lineup and giving Nurse more playing time will not only improve the team's overall strength, but also help the team achieve better results in the playoffs. I believe that over time, the Philadelphia 76ers will go all the way under the leadership of Nurse Simus and usher in a brighter future.
Disclaimer: If the content of the article involves the content of the work, copyright pictures or other issues, please contact the author of this number within 30 days, if the situation is true, we will delete the responsible article as soon as possible. The article is for reference only and does not constitute any investment or application advice.